Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Bullano M"'
Autor:
Xing S; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA, USA., Bullano M; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA, USA., Hale S; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA, USA., Lokhandwala T; Xcenda LLC, Carrollton, TX, USA., Murty S; Sarepta Therapeutics, Cambridge, MA, USA.
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2024 Dec 05; Vol. 81 (24), pp. 1278-1287.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sidonio RF Jr; Aflac Cancer and Blood Disorders Center, Egleston Hospital, Emory University School of Medicine, Atlanta, GA, USA., Lu A; Life Sciences Practice, Charles River Associates, Boston, MA, USA., Hale S; US Medical, Takeda Pharmaceuticals USA Inc, Lexington, MA, USA., Caicedo J; US Medical, Takeda Pharmaceuticals USA Inc, Lexington, MA, USA., Bullano M; US Medical, Takeda Pharmaceuticals USA Inc, Lexington, MA, USA., Xing S; US Medical, Takeda Pharmaceuticals USA Inc, Lexington, MA, USA.
Publikováno v:
Expert review of hematology [Expert Rev Hematol] 2024 Jun; Vol. 17 (6), pp. 261-268. Date of Electronic Publication: 2024 May 24.
Autor:
Schultz BG; US Medical Affairs Outcomes Research, Takeda Pharmaceuticals U.S.A., Inc., Lexington, Massachusetts, USA., Bullano M; US Medical Affairs Outcomes Research, Takeda Pharmaceuticals U.S.A., Inc., Lexington, Massachusetts, USA., Paratane D; Health Economics and Outcomes Research, Anlitiks, Inc., Windermere, Florida, USA., Rajagopalan K; Health Economics and Outcomes Research, Anlitiks, Inc., Windermere, Florida, USA.
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2024 Apr; Vol. 26 (2), pp. e14216. Date of Electronic Publication: 2024 Jan 14.
Publikováno v:
In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2
Autor:
Xing S; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA, USA., Bullano M; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA, USA., Hale S; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA, USA., Lokhandwala T; Cencora, Conshohocken, PA, USA., DeYoung K; Cencora, Conshohocken, PA, USA., Murty S; Cencora, Conshohocken, PA, USA.
Publikováno v:
Journal of medical economics [J Med Econ] 2024 Jan-Dec; Vol. 27 (1), pp. 1086-1098. Date of Electronic Publication: 2024 Aug 22.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xing S; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA., Batt K; Sprouts Consulting Ltd., Raleigh, NC., Kuharic M; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA.; Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago., Bullano M; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA., Caicedo J; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA., Chakladar S; Complete HEOR Solutions (CHEORS), North Wales, PA., Markan R; Complete HEOR Solutions (CHEORS), North Wales, PA., Farahbakhshian S; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2023 Jun; Vol. 29 (6), pp. 626-634.
Autor:
Escobar M; University of Texas Health Science Center, Houston, TX, USA., Bullano M; Takeda Pharmaceuticals USA, Lexington, MA, USA., Mokdad AG; Takeda Pharmaceuticals USA, Lexington, MA, USA., Caicedo J; Takeda Pharmaceuticals USA, Lexington, MA, USA., Schultz BG; Takeda Pharmaceuticals USA, Lexington, MA, USA., Fan Q; Takeda Pharmaceuticals USA, Lexington, MA, USA., Verma S; STATinMED, Ann Arbor, MI, USA.
Publikováno v:
Expert review of hematology [Expert Rev Hematol] 2023 Jun; Vol. 16 (6), pp. 467-474. Date of Electronic Publication: 2023 Apr 28.
Autor:
Batt K; Sprouts Consulting Ltd., Raleigh, North Carolina, USA., Xing S; Takeda Pharmaceuticals U.S.A., Inc., Lexington, Massachusetts, USA., Kuharic M; Takeda Pharmaceuticals U.S.A., Inc., Lexington, Massachusetts, USA.; Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago, Illinois, USA., Bullano M; Takeda Pharmaceuticals U.S.A., Inc., Lexington, Massachusetts, USA., Caicedo J; Takeda Pharmaceuticals U.S.A., Inc., Lexington, Massachusetts, USA., Chakladar S; Complete HEOR Solutions (CHEORS), North Wales, Pennsylvania, USA., Markan R; Complete HEOR Solutions (CHEORS), North Wales, Pennsylvania, USA., Farahbakhshian S; Takeda Pharmaceuticals U.S.A., Inc., Lexington, Massachusetts, USA.
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2023 May; Vol. 29 (3), pp. 809-818. Date of Electronic Publication: 2023 May 06.